Herrera F. LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT. Mediterr J Hematol Infect Dis [Internet]. 2024 Apr. 30 [cited 2024 Nov. 21];16(1):e2024039. Available from: https://www.mjhid.org/mjhid/article/view/5613